Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.1.1.3 (
HSD
)
3,464
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Adult virgin 4-day cycling synchronized Charles foster females were treated subcutaneously (0.05 mg/kg body wt/day) with sodium acetate (control), lead acetate or cadmium acetate alone, or both during gestational period, with pretreatment of 5 days prior to mating. There were no alterations in reproductive performance in all metal-treated groups. Implantation enzymes, cathepsin-D and alkaline phosphatase, activity were altered, but no change in the reproductive performance was observed. The key steroidogenic enzymes of ovary and placenta (3beta-
HSD
and 17beta-HSD), along with gonadal steroids, were affected the most in cadmium and combined treated animals whereas lead-treated animals showed a minimum change compared to the control group. Maximum displacement of zinc bound to metallothionein was more in cadmium and combined treated rats when compared to other metal-treated groups. Biomolecules such as glycogen, protein, RNA, DNA, and protein content were affected in all metal-treated groups, whereas cadmium-treated animals showed greater effect. General parameters of toxicity such as alkaline phosphatase, serum
glutamate pyruvate transaminase
, and creatinine were altered but were within the normal range. Biochemical effects are correlated with metals accumulated in blood, reproductive tissue such as placenta and ovary.
...
PMID:Biochemical effects of gestational coexposure to lead and cadmium on reproductive performance, placenta, and ovary. 1897 98